Serge Belanger
Stock Analyst at Needham
Total Price Targets
12
Stocks Covered
10
Sectors
Healthcare
Most Recent
Dec 22, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Serge Belanger
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CYTK | Cytokinetics, Incorporated | $84.00 | $64.40 | +30.4% | 2 | Dec 22, 2025 |
| MLTX | MoonLake Immunotherapeutics | $20.00 | $16.71 | +19.7% | 2 | Sep 30, 2025 |
| LQDA | Liquidia Corporation | $19.00 | $38.21 | -50.3% | 1 | Jan 9, 2025 |
| KALV | KalVista Pharmaceuticals, Inc. | $28.00 | $26.66 | +5.0% | 1 | Nov 5, 2024 |
| VRDN | Viridian Therapeutics, Inc. | $19.00 | $13.41 | +41.7% | 1 | Sep 11, 2024 |
| NAMS | NewAmsterdam Pharma Company N.V. | $36.00 | $28.65 | +25.7% | 1 | Aug 28, 2024 |
| ARQT | Arcutis Biotherapeutics, Inc. | $18.00 | $23.37 | -23.0% | 1 | May 15, 2024 |
| HRTX | Heron Therapeutics, Inc. | $5.00 | $1.28 | +289.1% | 1 | Mar 13, 2024 |
| ESPR | Esperion Therapeutics, Inc. | $12.00 | $3.12 | +284.7% | 1 | May 4, 2022 |
| AKBA | Akebia Therapeutics, Inc. | $7.00 | $1.41 | +396.5% | 1 | Mar 3, 2022 |
Recent Activity
- Dec 22, 2025— Set$84.00price target onCYTK(Cytokinetics, Incorporated)
- Sep 30, 2025— Set$20.00price target onMLTX(MoonLake Immunotherapeutics)
- Jan 9, 2025— Set$19.00price target onLQDA(Liquidia Corporation)
- Nov 5, 2024— Set$28.00price target onKALV(KalVista Pharmaceuticals, Inc.)
- Sep 11, 2024— Set$19.00price target onVRDN(Viridian Therapeutics, Inc.)
- Aug 28, 2024— Set$36.00price target onNAMS(NewAmsterdam Pharma Company N.V.)
- May 23, 2024— Set$72.00price target onCYTK(Cytokinetics, Incorporated)
- May 15, 2024— Set$18.00price target onARQT(Arcutis Biotherapeutics, Inc.)
- Mar 13, 2024— Set$5.00price target onHRTX(Heron Therapeutics, Inc.)
- Aug 31, 2023— Set$76.00price target onMLTX(MoonLake Immunotherapeutics)
- May 4, 2022— Set$12.00price target onESPR(Esperion Therapeutics, Inc.)
- Mar 3, 2022— Set$7.00price target onAKBA(Akebia Therapeutics, Inc.)
Frequently Asked Questions
Who is Serge Belanger?
Serge Belanger is a stock analyst at Needham covering 10 stocks primarily in Healthcare. They have issued 12 price targets since Mar 3, 2022.
What stocks does Serge Belanger cover?
Serge Belanger currently covers 10 stocks, including CYTK, MLTX, LQDA, KALV, VRDN.
What is Serge Belanger's latest price target?
Serge Belanger's most recent price target was $84.00 on CYTK (Cytokinetics, Incorporated), set on Dec 22, 2025.
What is Serge Belanger's highest price target?
Serge Belanger's highest issued price target is $84.00 on CYTK, set on Dec 22, 2025.
More Analysts at Needham
Coverage based on publicly published price targets. Not investment advice.